Acrivon Therapeutics (ACRV) Return on Equity [ROE] (2022 - 2026)
Acrivon Therapeutics (ACRV) recorded Return on Equity [ROE] of -86.04% in Q2 2026, down 23.81 percentage points from -62.23% a year earlier and down 6.86 percentage points from the prior quarter.
Powered by 
Analysis
Acrivon Therapeutics (ACRV) Return on Equity [ROE] (2022 - 2026) Analysis & Trends
For FY2025, Acrivon Therapeutics reported Return on Equity [ROE] of -58.15%, up 1.72 percentage points from FY2024.
- Annual Return on Equity [ROE] has a three-year change of -15.65 percentage points (FY2022 to FY2025).
- Across earlier years, Return on Equity [ROE] came in at -59.87% in FY2024 (-13.86 pp), -46.01% in FY2023 (-3.51 pp) and -42.50% in FY2022.
- The Q2 2026 figure is the lowest quarterly Return on Equity [ROE] in data going back to Q4 2022.
- On a year-over-year basis, Return on Equity [ROE] has declined for five consecutive quarters, with an average year-over-year change of -12.74 percentage points over the last eight quarters.
- Peak year-over-year performance for Return on Equity [ROE] in the last five years was a gain of 6.14 percentage points in Q1 2025, against a drop of 38.19 percentage points in Q1 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at -79.17% (Q1 2026), -69.77% (Q4 2025) and -65.49% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 82.09% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 25.32% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 7.21% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 84.40% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 21.39% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 83.75% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -18.38% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 4.97% |
| 10 | Acrivon Therapeutics | 85.27 Mn | 85.27 Mn | - | -86.04% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -86.04% |
| Mar 31, 2026 | -79.17% |
| Dec 31, 2025 | -69.77% |
| Sep 30, 2025 | -65.49% |
| Jun 30, 2025 | -62.23% |
| Mar 31, 2025 | -55.28% |
| Dec 31, 2024 | -47.74% |
| Sep 30, 2024 | -41.31% |
| Jun 30, 2024 | -47.09% |
| Mar 31, 2024 | -61.42% |
| Dec 31, 2023 | -51.75% |
| Sep 30, 2023 | -38.27% |
| Jun 30, 2023 | -31.03% |
| Mar 31, 2023 | -23.23% |
| Dec 31, 2022 | -50.08% |
API Access
Acrivon Therapeutics Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ACRV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "ACRV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ACRV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();